TY  - CHAP
M1  - Book, Section
TI  - Chapter 6B. Phase II Drug-Metabolizing Enzymes
A1  - Murray, Michael
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
Y1  - 2013
N1  - 
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - To  outline  the  major  pathways  of  drug  biotransformation  mediated  by  phase  II  enzymes.To  define  the  properties  and  multiplicity  of  genes  that  encode  phase  II  biotransformation  enzymes.To  emphasize  the  extent  of  genetic  variation  in  important  genes  that  mediate  phase  II  drug  biotransformation.To  provide  established  examples  of  pharmacogenetic  variants  in  phase  II  drug-metabolizing  enzymes  that  influence  drug  therapy.To  evaluate  the  evidence  for  additional  examples  of  pharmacogenetic  variation  in  drug-metabolizing  enzymes  that  influence  therapeutic  outcomes  with  drugs.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56878198
ER  -